122 related articles for article (PubMed ID: 32698242)
21. Serum and peritoneal fluid levels of interleukin-6 and interleukin-37 as biomarkers for endometriosis.
Jiang J; Jiang Z; Xue M
Gynecol Endocrinol; 2019 Jul; 35(7):571-575. PubMed ID: 30632819
[TBL] [Abstract][Full Text] [Related]
22. Analysis of positron emission tomography/computed tomography in patients to differentiate between malignant transformation of endometrioma and endometrioma.
Kusunoki S; Ota T; Kaneda H; Kimura M; Terao Y; Takeda S
Int J Clin Oncol; 2016 Dec; 21(6):1136-1141. PubMed ID: 27380167
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal cytokine level in patients with peritoneal surface malignancies. A study of the RENAPE (French Network for Rare Peritoneal Malignancies).
Vlaeminck-Guillem V; Bienvenu J; Isaac S; Grangier B; Golfier F; Passot G; Bakrin N; Rodriguez-Lafrasse C; Gilly FN; Glehen O
Ann Surg Oncol; 2013 Aug; 20(8):2655-62. PubMed ID: 23519518
[TBL] [Abstract][Full Text] [Related]
24. Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer?
Anastasi E; Manganaro L; Granato T; Benedetti Panici P; Frati L; Porpora MG
Dis Markers; 2013; 35(5):331-5. PubMed ID: 24191126
[TBL] [Abstract][Full Text] [Related]
25. Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examination.
Chechlinska M; Kaminska J; Markowska J; Kramar A; Steffen J
Int J Biol Markers; 2007; 22(3):172-80. PubMed ID: 17922459
[TBL] [Abstract][Full Text] [Related]
26. Plasma urocortin levels in the diagnosis of ovarian endometriosis.
Florio P; Reis FM; Torres PB; Calonaci F; Toti P; Bocchi C; Linton EA; Petraglia F
Obstet Gynecol; 2007 Sep; 110(3):594-600. PubMed ID: 17766605
[TBL] [Abstract][Full Text] [Related]
27. Effect of Endometrioma cystectomy on cytokines of follicular fluid and IVF outcomes.
Liang Y; Yang X; Lan Y; Lei L; Li Y; Wang S
J Ovarian Res; 2019 Oct; 12(1):98. PubMed ID: 31639028
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of interleukin-6 levels in peritoneal fluid for detection of endometriosis.
Wickiewicz D; Chrobak A; Gmyrek GB; Halbersztadt A; Gabryś MS; Goluda M; Chełmońska-Soyta A
Arch Gynecol Obstet; 2013 Oct; 288(4):805-14. PubMed ID: 23553197
[TBL] [Abstract][Full Text] [Related]
29. [Serum cytokines in patients with ovarian cancer and benign ovarian cysts].
Nowak M; Szpakowski M; Malinowski A; Wieczorek A; Maciołek-Blewniewska G; Wilczyński JR; Szpakowski A; Wierzbicka E; Małafiej E; Oszukowski P
Ginekol Pol; 2001 Dec; 72(12A):1444-8. PubMed ID: 11883294
[TBL] [Abstract][Full Text] [Related]
30. Application of serum markers in diagnosis and staging of ovarian endometriosis.
Tang T; Lai H; Huang X; Gu L; Shi H
J Obstet Gynaecol Res; 2021 Apr; 47(4):1441-1450. PubMed ID: 33448139
[TBL] [Abstract][Full Text] [Related]
31. [Measurement of serum human epididymis secretory protein 4 combined with CA125 assay in differential diagnosis of endometriosis cyst and ovarian benign and malignant tumors].
Liu YN; Ye X; Cheng HY; Cheng YX; Fu TY; Chen J; Chang XH; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):363-6. PubMed ID: 20646446
[TBL] [Abstract][Full Text] [Related]
32. Comparing the Copenhagen Index (CPH-I) and Risk of Ovarian Malignancy Algorithm (ROMA): Two equivalent ways to differentiate malignant from benign ovarian tumors before surgery?
Yoshida A; Derchain SF; Pitta DR; Andrade LA; Sarian LO
Gynecol Oncol; 2016 Mar; 140(3):481-5. PubMed ID: 26825617
[TBL] [Abstract][Full Text] [Related]
33. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
[TBL] [Abstract][Full Text] [Related]
34. Selected cytokines and glycodelin A levels in serum and peritoneal fluid in girls with endometriosis.
Drosdzol-Cop A; Skrzypulec-Plinta V
J Obstet Gynaecol Res; 2012 Oct; 38(10):1245-53. PubMed ID: 22563871
[TBL] [Abstract][Full Text] [Related]
35. The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis.
Kadija S; Stefanovic A; Jeremic K; Radojevic MM; Nikolic L; Markovic I; Atanackovic J
Int J Gynecol Cancer; 2012 Feb; 22(2):238-44. PubMed ID: 22214964
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of ovarian cysts and tumors by using T2 star mapping.
Takahashi N; Yoshino O; Hayashida E; Nakamura M; Hori M; Iwahata S; Onda T; Unno N; Fujii T; Osuga Y
J Obstet Gynaecol Res; 2020 Jan; 46(1):140-146. PubMed ID: 31742851
[TBL] [Abstract][Full Text] [Related]
37. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
38. Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas.
Iwabe T; Harada T; Sakamoto Y; Iba Y; Horie S; Mitsunari M; Terakawa N
Fertil Steril; 2003 Aug; 80(2):300-4. PubMed ID: 12909491
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma.
Yi YC; Wang SC; Chao CC; Su CL; Lee YL; Chen LY
J Clin Lab Anal; 2010; 24(5):357-62. PubMed ID: 20872572
[TBL] [Abstract][Full Text] [Related]
40. Concomitant measurements of interleukin-6 (IL-6) in serum and peritoneal fluid of patients with benign and malignant ovarian tumors.
Schröder W; Ruppert C; Bender HG
Eur J Obstet Gynecol Reprod Biol; 1994 Jul; 56(1):43-6. PubMed ID: 7982516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
